Tech war: DeepSeek’s V3.1 model emerges as ‘key pillar’ for China’s chip self-sufficiency


The Hangzhou-based start-up’s updated model, which supports an innovative data format called UE8M0 FP8, was “ushering in a booming domestic computing power chain”, Huatai Securities analysts said in a research note on Tuesday.

That architecture showed that the synergy between mainland-designed software and chips would realise significant results, according to the report.

FP8, known as floating-point 8, is a format that reduces precision to speed up AI training and inference by using less memory and bandwidth. UE8M0, another 8-bit format, is said to increase training efficiency, which reduces hardware requirements by cutting memory use by up to 75 per cent.

The V3.1’s data format represents “a key pillar for building an independent and controllable AI ecosystem” for China, as the country establishes a “healthy ecosystem for the coordinated development of hardware, software and applications in the field of AI computing”, according to a report on Sunday by Haitong Securities.

The analysts’ assessments reflected the growing efforts in the country’s AI sector and semiconductor industry to push forward Beijing’s tech self-sufficiency agenda amid US export restrictions on China and rising geopolitical tensions.
Chinese AI and semiconductor companies are raising the stakes in the country’s tech self-sufficiency efforts. Photo: Shutterstock
Chinese AI and semiconductor companies are raising the stakes in the country’s tech self-sufficiency efforts. Photo: Shutterstock
  • Related Posts

    Brazil’s visa-free entry for Chinese visitors sparks rise in South America travel demand

    Travel agencies are seeing a notable rise in inquiries and bookings for trips to South America by tourists from mainland China after Brazil’s visa-free entry policy for visitors from the…

    Continue reading
    China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

    Jiangsu Hengrui Pharmaceutical, China’s largest drug company by market capitalisation, has signed a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) worth up to US$15.2…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *